2.4 Parallel session: Diarrhoeal diseases and antimicrobial resistance

Presentations:

OA-539 - Development of a machine learning-based early warning system (EWS) for predicting diarrhea outbreaks among under-five children: a case of selected regions in Tanzania

Patrick Kimu, Kilimanjaro Clinical Research Institute, Tanzania

OA-270 - Efficacy, and immunogenicity of ETVAX, an oral multivalent whole-cell vaccine against moderate-to-severe enterotoxigenic E. coli (ETEC) diarrhea in Gambian children

M. Jahangir Hossain, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, The Gambia

OA-058 - A phase 2 trial of the iNTS-GMMA vaccine against invasive nontyphoidal salmonellosis in adults, children, and infants from Africa: study design and initial safety data

Yasir Shitu Isa, GSK Vaccines for Global Health (GVGH),            Italy

OA-083 - Multidrug resistant and distribution of ß-lactamase genes among diarrheagenic Escherichia coli isolated from under-five children in central Ethiopia

Tizazu Zelelie, Debre Berhan University, Ethiopia

OA-565 - Whole genome sequencing reveals fluoroquinolone resistance in Shigella isolates from children under five in Lusaka, Zambia

Mwelwa            Chibuye, Center for Infectious Diseases Research in Zambia (CIDRZ), Zambia

OA-731 - Frequency, patterns and appropriateness of antibiotic prescription in patients presenting with fever in sub-Saharan African health facilities: results from a large multi-country prospective cohort

Karifa Kourouma, Centre National de Formation et de Recherche en Santé Rurale de Maferinyah (CNFRSR), Guinea